iamwhatiseem
Diamond Member
Exactly zero positive.
This is a campaign by NYT against him.
Clearly.
In a recent interview - I like how Ramaswamy responded.
If you don't want to watch it... in a nutshell, the article NYT ran specifically about how he made $millions why other shareholders lost money on a failed Alzheimer medicine bid.
"They engaged in all 3 types of lying by the media - all in one article"
1) Outright lie. He did not sell one share of his holdings of that bid when it failed to pass FDA.
2) Lie by Omission. They said "he made $100s millions during the loss". Yes he did. Because his company broke the record for the highest number of drugs to gain FDA approval by a startup in U.S. history during the same time period. OBVIOUSLY he made money.
3) Stylistic lying. Telling something that is true, but doing so in such a way as to leave the impression the opposite is true. "Because the way he orchestrated his company, it was protected from the losses from the failed drug". The way he set up his company was done 3 years prior to this drug. It was not designed to avoid losses, it was designed to allow laboratories and chemist to be able to invest in a specific drug they are developing "skin in the game" instead of how other large pharma companies are designed to only allow people to invest in the company as a whole. This allows people who have a stake to make considerably more money than other companies from a drug they are developing, but by the same token - yes it increases chance of loss if it fails.
This is a campaign by NYT against him.
Clearly.
In a recent interview - I like how Ramaswamy responded.
If you don't want to watch it... in a nutshell, the article NYT ran specifically about how he made $millions why other shareholders lost money on a failed Alzheimer medicine bid.
"They engaged in all 3 types of lying by the media - all in one article"
1) Outright lie. He did not sell one share of his holdings of that bid when it failed to pass FDA.
2) Lie by Omission. They said "he made $100s millions during the loss". Yes he did. Because his company broke the record for the highest number of drugs to gain FDA approval by a startup in U.S. history during the same time period. OBVIOUSLY he made money.
3) Stylistic lying. Telling something that is true, but doing so in such a way as to leave the impression the opposite is true. "Because the way he orchestrated his company, it was protected from the losses from the failed drug". The way he set up his company was done 3 years prior to this drug. It was not designed to avoid losses, it was designed to allow laboratories and chemist to be able to invest in a specific drug they are developing "skin in the game" instead of how other large pharma companies are designed to only allow people to invest in the company as a whole. This allows people who have a stake to make considerably more money than other companies from a drug they are developing, but by the same token - yes it increases chance of loss if it fails.